Pharmaceuticals & Biotech South African Community
Our community narratives are driven by numbers and valuation.
Pharmaceuticals & Biotech South African Investing Ideas
Commercial Pharma And GLP-1 Expansion Will Empower Future Progress
Key Takeaways Steady commercial pharma growth through strategic market focus in China and Russia enhances revenue stability. GLP-1 and insulin manufacturing expansion offers substantial long-term revenue and margin growth potential.Read more
128
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
29users have followed this narrative
AN
R120.6
21.6% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
5.58% p.a.
Profit Margin
13.23%
Future PE
12.59x
Price in 2028
R191.73
